new indications for glp-1 drugs Drugs: Where We Are and Where We're Going — Summit Re The everything drugs: from weight
Description
Fras JP, Davies MJ, Rosenstock J et al (2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
.svg?mw=810&hash=8DDE12336D7D7D5D6E4313F13293B26D)
In 1986, Danish scientist Jens Juul Holst discovered that the gut hormone GLP-1 stimulates insulin and suppresses appetite
42 Cardiovascular effects are being examined in the SUMMIT trial
A 5mg dose requires 0.63mL
doi: 10.1177/1060028017689878 64 Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus
